{
    "2019-10-23": [
        [
            {
                "time": "",
                "original_text": "7 5 亿 ！ 知 名 药 企 出 售 两 大 品 种",
                "features": {
                    "keywords": [
                        "出售",
                        "知名药企",
                        "两大品种"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "复 星 医 药 ： 拟 为 控 股 子 公 司 复 星 医 疗 申 请 3 亿 元 的 贷 款 提 供 连 带 责 任 保 证 担 保  大 额 借 贷 担 保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "贷款担保",
                        "3亿元"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复 星 医 药 ( 0 2 1 9 6 . H K ) 拟 为 子 公 司 复 星 医 疗 提 供 3 亿 元 贷 款 担 保  大 额 借 贷 担 保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "贷款担保",
                        "3亿元"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【 权 益 变 动 】 复 星 医 药 ( 0 2 1 9 6 - H K ) 获 E d i n b u r g h P a r t n e r s 增 持 7 3 . 8 万 股",
                "features": {
                    "keywords": [
                        "权益变动",
                        "复星医药",
                        "增持",
                        "Edinburgh Partners",
                        "73.8万股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医 药 公 司 2 0 1 9 三 季 报 披 露 期 ， 3 条 主 线 被 继 续 看 好 ！",
                "features": {
                    "keywords": [
                        "医药公司",
                        "三季报",
                        "三条主线",
                        "看好"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "出 售 和 睦 家 部 分 股 份 获 复 星 医 药 股 东 大 会 高 票 通 过",
                "features": {
                    "keywords": [
                        "出售",
                        "和睦家",
                        "股份",
                        "股东大会",
                        "高票通过"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A D C 药 物 P K ！ 荣 昌 生 物 R C 4 8 适 应 症 多   百 奥 泰 B A T 8 0 0 1 进 展 快",
                "features": {
                    "keywords": [
                        "ADC药物",
                        "荣昌生物",
                        "RC48",
                        "百奥泰",
                        "BAT8001",
                        "进展快"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}